Table 1 Mean survival times among patients with and without high BMP2 expression levels.

From: BMP2 promotes lung adenocarcinoma metastasis through BMP receptor 2-mediated SMAD1/5 activation

 

Median for survival time

Median

SE

95% Confidence Interval

Lower bound

Upper bound

Intensity of BMP2

    

Low

2797

361.277

2088.898

3505.102

Moderate and high

2799

173.386

2459.163

3138.837

Overall

2799

139.693

2525.201

3072.799

  1. Significance was determined by the Log-rank test (p = 0.603).
Back to article page